![Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus | Nature Reviews Endocrinology Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrendo.2016.86/MediaObjects/41574_2016_Article_BFnrendo201686_Fig1_HTML.jpg)
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus | Nature Reviews Endocrinology
![From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-021-01281-y/MediaObjects/12933_2021_1281_Fig3_HTML.png)
From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes | Cardiovascular Diabetology | Full Text
![What Is a Logical Approach for Choosing Among New Agents for Patients With Type 2 Diabetes? | Consultant360 What Is a Logical Approach for Choosing Among New Agents for Patients With Type 2 Diabetes? | Consultant360](https://s3.amazonaws.com/HMP/c360/imported/transfer/Screen_Shot_2013-02-14_at_10.03.01_AM.png)
What Is a Logical Approach for Choosing Among New Agents for Patients With Type 2 Diabetes? | Consultant360
![Type 2 Diabetes Mellitus Treatment & Management: Approach Considerations, Pharmacologic Therapy, Management of Glycemia Type 2 Diabetes Mellitus Treatment & Management: Approach Considerations, Pharmacologic Therapy, Management of Glycemia](https://img.medscapestatic.com/pi/meds/ckb/06/30206tn.jpg)
Type 2 Diabetes Mellitus Treatment & Management: Approach Considerations, Pharmacologic Therapy, Management of Glycemia
![Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis - eClinicalMedicine Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/attachment/9195c044-2bd6-431f-b89c-f9ed427b074c/gr1_lrg.jpg)
Age, sex, race, BMI, and duration of diabetes differences in cardiovascular outcomes with glucose lowering drugs in type 2 diabetes: A systematic review and meta-analysis - eClinicalMedicine
![Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities: Trends in Molecular Medicine Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/5267cddc-c8ff-4c06-949f-f18a562c3ea9/gr1_lrg.jpg)
Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities: Trends in Molecular Medicine
![Two popular diabetes drugs outperformed others in large clinical trial - Florida Hospital News and Healthcare Report Two popular diabetes drugs outperformed others in large clinical trial - Florida Hospital News and Healthcare Report](https://southfloridahospitalnews.com/wp-content/uploads/2022/09/nih-20220921-infographic.jpg)
Two popular diabetes drugs outperformed others in large clinical trial - Florida Hospital News and Healthcare Report
![Light-activated drug could reduce side effects of diabetes medication | Imperial News | Imperial College London Light-activated drug could reduce side effects of diabetes medication | Imperial News | Imperial College London](https://www.imperial.ac.uk/news/image/mainnews2012/24278.jpg)
Light-activated drug could reduce side effects of diabetes medication | Imperial News | Imperial College London
![Novel Diabetes Drugs and the Cardiovascular Specialist | Journal of the American College of Cardiology Novel Diabetes Drugs and the Cardiovascular Specialist | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/8b57e33a-1dc4-4e4b-99e9-26642a71e99c/fx1.jpg)
Novel Diabetes Drugs and the Cardiovascular Specialist | Journal of the American College of Cardiology
![Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279141/bin/pharmaco-agent-diab2-Image002.jpg)